<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00883467</url>
  </required_header>
  <id_info>
    <org_study_id>IPC in MRI 040908</org_study_id>
    <nct_id>NCT00883467</nct_id>
  </id_info>
  <brief_title>The Effects of Preconditioning on Intramuscular High-Energy Phosphate Levels During Ischemia</brief_title>
  <acronym>IPC in MRI</acronym>
  <official_title>The Effects of Preconditioning on Intramuscular High-Energy Phosphate Levels During Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Ischemia reperfusion injury may be reduced by ischemic preconditioning. This projects aims to
      show the effects of short and long time ischemic preconditioning (both sequences 3 x 5
      minutes) during and after an ischemic period of 20 minutes in healthy subjects by functional
      MRI. Ischemia is produces by cuff inflation to a suprasystolic pressure on one tight. Signal
      is acquired from calf muscles.

      A cross-over design of 4 to 8 study periods is used, 4 different study days with 2 different
      MR measurement methods (BOLD imaging and high energy phosphates) are planned.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cellular high energy phosphate levels and venous pH concentration for 31P MRS</measure>
    <time_frame>during and 30 min after ischemia</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Main outcome variables: Change in cellular oxygen saturation for BOLD MRI</measure>
    <time_frame>during and 30 minutes after ischemia</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum markers of myocellular injury (myoglobin, creatine-kinase)</measure>
    <time_frame>prior to, directly and 24 hours after ischemia</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Ischemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>baseline MR signal prior to, during and 30 minutes after an ischemic period of 20 minutes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>baseline MR signal prior to, during and 30 minutes after an ischemic period of 20 minutes with additional 5 minutes of cuff stenosis directly after cuff release</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>short time preconditioning, other details according arm 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>long time preconditioning, other details according arm 2</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>preconditioning</intervention_name>
    <description>3 times of five minutes ischemia, produced by cuff inflation to a suprasystolic pressure positioned on the thigh</description>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>no preconditioning</intervention_name>
    <description>no preconditioning</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men aged between 18 and 45 years

          -  Nonsmoker for more than 3 months

          -  Body mass index between 18 and 25 kg/m2

          -  Normal findings in medical history and physical examination unless the investigator
             considers an abnormality to be clinically irrelevant

        Exclusion Criteria:

          -  Regular use of medication, abuse of alcoholic beverages, participation in a clinical
             trial in the 3 weeks preceding the study

          -  Evidence of hypertension, pathologic hyperglycemia, hyperlipidemia

          -  Treatment in the previous 3 weeks with any drug including over-the-counter drugs

          -  Symptoms of a clinically relevant illness in the 2 weeks before the first study day

          -  Blood donation during the previous 3 weeks

          -  Any metallic, electric, electronic or magnetic device or object not removable

          -  Claustrophobia
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Wolzt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MUV, Department of Clinical Pharmacology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Vienna, Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2009</study_first_submitted>
  <study_first_submitted_qc>April 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 17, 2009</study_first_posted>
  <last_update_submitted>April 16, 2009</last_update_submitted>
  <last_update_submitted_qc>April 16, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 17, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. Michael Wolzt</name_title>
    <organization>Medical University of Vienna, Department of Clinical Pharmacology</organization>
  </responsible_party>
  <keyword>Ischemic Preconditioning</keyword>
  <keyword>functional MRI</keyword>
  <keyword>BOLD</keyword>
  <keyword>Reperfusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

